-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
UnitedHealth Group Incorporated Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$255.64 B | $285.27 B | $322.13 B | $367.53 B | $400.28 B |
| Cost of Revenue |
|
$190.14 B | $217.95 B | $244.55 B | $280.66 B | $310.88 B |
| Gross Profit |
|
$65.50 B | $67.33 B | $77.59 B | $86.87 B | $89.40 B |
| Research & Development |
|
- | - | - | - | - |
| Selling,General & Administrative |
|
- | - | - | $54.63 B | $57.11 B |
| Operating Expense |
|
$44.60 B | $45.68 B | $51.18 B | $54.51 B | $57.11 B |
| Operating Income |
|
$22.41 B | $23.97 B | $28.44 B | $32.36 B | $32.29 B |
| Net Income |
|
$15.40 B | $17.29 B | $20.12 B | $22.38 B | $14.41 B |
UnitedHealth Group Incorporated Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$19.78 B | $23.91 B | $27.91 B | $29.63 B | $29.11 B |
| Inventories |
|
- | - | - | - | - |
| Total Current Assets |
|
$53.72 B | $61.76 B | $69.07 B | $78.44 B | $85.78 B |
| Property,Plant and Equipment |
|
$8.63 B | $8.97 B | $10.13 B | $11.45 B | $10.55 B |
| Goodwill |
|
$71.34 B | $75.80 B | $93.35 B | $103.73 B | $106.73 B |
| Total Assets |
|
$197.29 B | $212.21 B | $245.71 B | $273.72 B | $298.28 B |
| Total Liabilities |
|
$126.75 B | $135.73 B | $159.36 B | $174.80 B | $195.69 B |
| Retained Earnings |
|
$69.30 B | $77.13 B | $86.16 B | $95.77 B | $96.04 B |
| Total Shareholder Equity |
|
$65.49 B | $71.76 B | $77.77 B | $88.76 B | $92.66 B |
| Common Stock |
|
$10.00 M | $10.00 M | $9.00 M | $9.00 M | $9.00 M |
UnitedHealth Group Incorporated Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$2.89 B | $3.10 B | $3.40 B | $3.97 B | $4.10 B |
| Dividends Payout |
|
-$4.58 B | -$5.28 B | -$5.99 B | -$6.76 B | -$7.53 B |
| Capital Expenditures (Capex) |
|
-$2.05 B | -$2.45 B | -$2.80 B | -$3.39 B | -$3.50 B |
| Free Cash Flow (FCF) |
|
$20.12 B | $19.89 B | $23.40 B | $25.68 B | $20.71 B |
UnitedHealth Group Incorporated Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$65.50 B | $67.33 B | $77.59 B | $86.87 B | $89.40 B |
| Gross Profit Margin (%) |
|
25.62% | 23.60% | 24.09% | 23.64% | 22.33% |
| Operating Income |
|
$22.41 B | $23.97 B | $28.44 B | $32.36 B | $32.29 B |
| Operating Income Margin (%) |
|
8.76% | 8.40% | 8.83% | 8.80% | 8.07% |
| Net Income |
|
$15.40 B | $17.29 B | $20.12 B | $22.38 B | $14.41 B |
| Net Income Margin (%) |
|
6.03% | 6.06% | 6.25% | 6.09% | 3.60% |
| EBITDA |
|
$25.30 B | $27.07 B | $31.84 B | $32.52 B | $9.77 B |
| EBITDA Margin (%) |
|
9.90% | 9.49% | 9.88% | 8.85% | 2.44% |
UnitedHealth Group Incorporated Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
23.52% | 24.09% | 25.87% | 25.22% | 15.55% |
| Return on Assets (ROA) |
|
7.81% | 8.15% | 8.19% | 8.18% | 4.83% |
| Debt to Equity |
|
66.37% | 64.11% | 74.09% | 70.46% | 83.00% |
| Debt to total asset |
|
22.03% | 21.68% | 23.45% | 22.85% | 25.78% |
| Enterprise value to revenue |
|
1.40 | 1.75 | 1.64 | 1.43 | 1.30 |
| Enterprise value to EBITDA |
|
14.16 | 18.40 | 16.63 | 16.17 | 53.39 |
| Enterprise value |
|
$358.29 B | $498.15 B | $529.45 B | $525.67 B | $521.54 B |
| Cash to Debt |
|
51.01% | 48.57% | 45.48% | 46.48% | 31.47% |
| Tax Rate (%) |
|
23.98% | 20.52% | 21.65% | 20.50% | 24.06% |
| Payout Ratio |
|
29.76% | 30.55% | 29.78% | 30.21% | 52.29% |
